The adjuvant activity of 29 kinds of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine was examined in guinea pigs. It was found that the D-manno-and D-galacto-type muramyldipeptides were as active as the D-gluco-type muramyldipeptide (MDP). The structural requirement of the carbohydrate moiety of analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine is discussed.
discussed.
The miniimal adjuvant-active subunit of the bacterial cell wall has been established to be Nacetylmuramyl-L-alanyl-D-isoglutamine (MDP) (8, 18) . The details of the immunological properties and relationships between the chemical structures and the immunological activities of MDP have been investigated (1-3, 5-7, 17, 20, 21) .
Recently, we have synthesized a variety of carbohydrate analogs of the muramyldipeptides to clarify the structural requirement in the carbohydrate moiety for adjuvant activity (9) (10) (11) (12) (13) (14) (15) (16) . In this paper, we describe the adjuvant activity of various carbohydrate analogs of MDP on the induction of delayed-type hypersensitivity to azobenzenearsonate (ABA)-N-acetyl-L-tyrosine (ABA-tyrosine) in guinea pigs.
MATERIALS AND METHODS Synthetic glycopeptides. The chemical structures of the glycopeptides tested in this study are shown in Fig. 1 . MDP was synthesized as described previously (19) . The synthesis of the MDP analogs in which the carbohydrate moiety of MDP was replaced with cyclohexanol (I), DL-(1,3/2)-1-acetamidocyclohexanediol (II), and its stereoisomer (III) was reported previously (10) . The positional isomers of MDP, like the D-lactyl-dipeptide linkage (IV, V) and the configurational isomers in which the D-glucosamine residue of MDP was replaced with D-mannosamine (VII), Dallosamine (IX), D-gulosamine (X), D-galactosamine (XI), and L-idosamine (XII) residues, were synthesized from D-glucosamine, except for the D-mannosamine analog, as described previously (9, 14) . The benzyl glycosides of MDP (XVI, XVII) were obtained as synthetic intermediates.
The chemically modified analogs of the C-2 substituents (XIII, XVIII, XIX) and the C-6 substituents (XV, XXII, XXIV) in the carbohydrate moiety of MDP were synthesized by the procedures reported previously (11) (12) (13) 15 (3a) . In this paper, the relationships between the chemical structure of the carbohydrate moiety (muramyl residue) of MDP and the adjuvant activity on the induction of delayed-type hypersensitivity in guinea pigs were examined.
That these cycitol analogs (compounds I through III) were inactive as adjuvants indicates that the carbohydrate structure was essential for the adjuvant activity of MDP (Table 1) observed that the configuration of the lactyl group in the muramyl residue of MDP must be in the D form for the manifestation of adjuvant activity, because the MDP isomer which consisted of the L-lactyl group in the muramyl residue was inactive as an adjuvant (16) .
Eight kinds of configurational isomers of MDP were synthesized, and their adjuvant activities were examined. Compounds VII and XI, which were D-mannosamine and D-galactosamine isomers of MDP, were equally active adjuvants as MDP at a 100-ug dose but were less active at a 10-,tg dose. These results suggest that the configurations at the C-2 and C-4 positions are not strictly limited, but the D-glucosamine form is favorable for the adjuvant activity of MDP analogs. Although the D-glucose isomer (XLII) of MDP was clearly active as an adjuvant, the L-glucose isomer (XIV) was inactive. These preliminary experimental data indicate that the configuration ofthe carbohydrate moiety should be in the D form, not in the L form, for the adjuvant activity. That the D-xylosamine isomer (XV) of MDP and the 6-deoxy compound (XXII) are inactive indicates that the hydroxymethyl group of the carbohydrate moiety of MDP is essential for adjuvant activity.
The benzylglycosides of MDP were also 
